Biotech aTyr Pharma Announces Positive Topline Results from Phase 2 Clinical Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications January 4, 2021
Biotech XOMA to Present at H.C. Wainwright Virtual BioConnect 2021 and Biotech Showcase Digital Conferences January 4, 2021
Biotech SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm January 4, 2021
Biotech DEADLINE ALERT for FBIO, SPLK, BSX, and QIWI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders January 4, 2021
Biotech Ampio Provides Update on Clinical Trials for Ampion(TM) Treatment of COVID-19 Patients January 4, 2021